Scholar Rock (NASDAQ:SRRK) Reaches New 52-Week High – What’s Next?

Scholar Rock Holding Corporation (NASDAQ:SRRK)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $51.63 and last traded at $50.0770, with a volume of 144137 shares changing hands. The stock had previously closed at $49.90.

Wall Street Analysts Forecast Growth

SRRK has been the topic of several analyst reports. Cantor Fitzgerald reiterated an “overweight” rating on shares of Scholar Rock in a report on Thursday, December 11th. Truist Financial upped their price target on shares of Scholar Rock from $44.00 to $55.00 and gave the company a “buy” rating in a report on Tuesday, March 3rd. HC Wainwright reiterated a “buy” rating and set a $58.00 price target on shares of Scholar Rock in a report on Tuesday, March 3rd. UBS Group started coverage on shares of Scholar Rock in a research note on Wednesday, January 7th. They issued a “buy” rating and a $60.00 target price on the stock. Finally, JPMorgan Chase & Co. upped their target price on shares of Scholar Rock from $47.00 to $50.00 and gave the stock an “overweight” rating in a research note on Monday, March 16th. Four equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Scholar Rock has an average rating of “Buy” and a consensus target price of $54.93.

Scholar Rock Price Performance

The company has a debt-to-equity ratio of 0.41, a quick ratio of 6.95 and a current ratio of 6.95. The firm has a market capitalization of $5.80 billion, a P/E ratio of -14.72 and a beta of 0.68. The stock’s 50 day simple moving average is $45.53 and its 200 day simple moving average is $41.23.

Scholar Rock (NASDAQ:SRRK) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.76) EPS for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.10. During the same quarter in the prior year, the company earned ($0.64) earnings per share. As a group, analysts expect that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Akshay Vaishnaw sold 20,438 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $42.70, for a total value of $872,702.60. Following the completion of the sale, the insider owned 595,767 shares of the company’s stock, valued at approximately $25,439,250.90. This represents a 3.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mo Qatanani sold 14,898 shares of the company’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $46.71, for a total transaction of $695,885.58. Following the completion of the sale, the insider directly owned 85,660 shares of the company’s stock, valued at $4,001,178.60. The trade was a 14.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 207,464 shares of company stock worth $9,157,423. 13.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Scholar Rock

Several hedge funds have recently modified their holdings of the business. Three Seasons Wealth LLC lifted its position in shares of Scholar Rock by 2.1% in the 4th quarter. Three Seasons Wealth LLC now owns 10,968 shares of the company’s stock worth $483,000 after purchasing an additional 222 shares during the period. IFP Advisors Inc lifted its position in shares of Scholar Rock by 294.1% in the 4th quarter. IFP Advisors Inc now owns 603 shares of the company’s stock worth $27,000 after purchasing an additional 450 shares during the period. Principal Financial Group Inc. boosted its position in Scholar Rock by 7.9% during the third quarter. Principal Financial Group Inc. now owns 6,214 shares of the company’s stock valued at $231,000 after purchasing an additional 456 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Scholar Rock by 151.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after purchasing an additional 525 shares during the last quarter. Finally, California State Teachers Retirement System grew its stake in Scholar Rock by 0.9% in the second quarter. California State Teachers Retirement System now owns 62,372 shares of the company’s stock valued at $2,209,000 after purchasing an additional 577 shares during the last quarter. Hedge funds and other institutional investors own 91.08% of the company’s stock.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).